Wernicke's Encephalopathy in Acute and Chronic Kidney Disease: A Systematic Review

J Ren Nutr. 2024 Mar;34(2):105-114. doi: 10.1053/j.jrn.2023.10.003. Epub 2023 Oct 13.

Abstract

Thiamine (vitamin B1) deficiency is relatively common in patients with kidney disease. Wernicke's encephalopathy (WE) is caused by vitamin B1 deficiency. Our aim was to systematically review the signs and symptoms of WE in patients with kidney disease. We conducted a systematic literature review on WE in kidney disease and recorded clinical and radiographic characteristics, treatment and outcome. In total 323 manuscripts were reviewed, which yielded 46 cases diagnosed with acute and chronic kidney disease and WE published in 37 reports. Prodromal characteristics of WE were loss of appetite, vomiting, weight loss, abdominal pain, and diarrhea. Parenteral thiamine 500 mg 3 times per day often led to full recovery, while Korsakoff's syndrome was found in those receiving low doses. To prevent WE in kidney failure, we suggest administering high doses of parenteral thiamine in patients with kidney disease who present with severe malnutrition and (prodromal) signs of thiamine deficiency.

Keywords: Wernicke's encephalopathy; clinical nutrition; dialysis; hemodialysis; kidney failure; perioneal dialysis; thiamine.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Humans
  • Renal Insufficiency, Chronic* / complications
  • Renal Insufficiency, Chronic* / drug therapy
  • Thiamine / therapeutic use
  • Thiamine Deficiency* / complications
  • Thiamine Deficiency* / diagnosis
  • Thiamine Deficiency* / drug therapy
  • Wernicke Encephalopathy* / diagnosis
  • Wernicke Encephalopathy* / drug therapy
  • Wernicke Encephalopathy* / etiology

Substances

  • Thiamine